ArticleBMC pulmonary medicine2024

Risk factors of immune checkpoint inhibitor-related pneumonitis after neoadjuvant immunochemotherapy for resectable NSCLC.

Zhirong Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.